| ¿µ¹® | hyperbilirubinemia | ÇÑ±Û | °íºô¸®·çºóÇ÷Áõ |
|---|---|---|---|
| ¼³¸í | Ç÷¾× ¼Ó¿¡ ÀÖ´Â ¾µ°³Áó»ö¼ÒÀÎ ºô¸®·çºóÀÇ ÃÑ ³óµµ°¡ Á¤»óº¸´Ù ¸¹¾ÆÁø »óÅÂ. ºô¸®·çºó¿¡´Â ±Û·çÅ©·Ð»ê°ú ÈÇÕÇÑ Á÷Á¢ºô¸®·çºó(Á¤»ó 0.4mg/dL ÀÌÇÏ)°ú ±×·¸Áö ¾ÊÀº °£Á¢ºô¸®·çºó(Á¤»ó 0.8mg/dL ÀÌÇÏ)ÀÇ µÎ Á¾·ù°¡ Àִµ¥, Ç÷¾× ¼ÓÀÇ µÎ ºô¸®·çºóÀ» ÇÕÇÑ ÃÑ ³óµµ°¡ Á¤»ó¼öÄ¡ÀÎ 1.2mg/dLº¸´Ù ¸¹¾ÆÁø °ÍÀ» ¸»ÇÑ´Ù. ºô¸®·çºóÀÌ È²»öÀ» ¶ì¹Ç·Î °íºô¸®·çºóÇ÷ÁõÀº Ȳ´Þ·Î¼ Ư¡Áö¾îÁø´Ù. °íºô¸®·çºóÇ÷Áõ¿¡ ÀÇÇÑ È²´ÞÀº ±× ¿øÀο¡ µû¶ó ¿ëÇ÷Ȳ´Þ, °£¼¼Æ÷Ȳ´Þ, Æó»öȲ´Þ·Î ³ª´«´Ù. ¿ëÇ÷Ȳ´ÞÀº ¸»ÃÊÇ÷¾×¿¡¼ ÀûÇ÷±¸°¡ ¸¹ÀÌ ÆÄ±«µÇ¸é¼ ºô¸®·çºóÀÌ ¸¹¾ÆÁ®¼ »ý±â°Ô µÇ´Â °ÍÀÌ´Ù. °£¼¼Æ÷Ȳ´ÞÀº °£¼¼Æ÷°¡ ¼Õ»óµÇ¾î ºô¸®·çºóÀ» ó¸®ÇÏ°í ¹è¼³½ÃŰ´Â ±â´ÉÀÌ ÀúÇÏµÇ¾î »ý±â´Â °ÍÀÌ´Ù. ´ëÇ¥ÀûÀÎ ¿¹´Â ±Þ¼º¹ÙÀÌ·¯½º°£¿°ÀÌ´Ù. Æó»öȲ´ÞÀº ºô¸®·çºóÀÌ ¹è¼³µÇ´Â Åë·ÎÀÎ ¾µ°³°üÀÌ Á¼¾ÆÁö°Å³ª ¸·Çô¼ ¾µ°³ÁóÀÌ ¹è¼³µÇÁö ¸øÇÏ¿© »ý±â´Â °ÍÀÌ´Ù. ´ëÇ¥ÀûÀÎ ¿¹´Â ¾µ°³µ¹(´ã¼®)Áõ, ¾µ°³±æ¿° µîÀÌ´Ù. ¿ëÇ÷Ȳ´Þ ¶§¿¡´Â Ç÷¾× ¼Ó¿¡ °£Á¢ºô¸®·çºóÀÌ, °£¼¼Æ÷Ȳ´Þ ¶§¿¡´Â °£Á¢ºô¸®·çºó°ú Á÷Á¢ ºô¸®·çºóÀÌ, Æó»öȲ´Þ ¶§¿¡´Â Á÷Á¢ºô¸®·çºóÀÌ ÁÖ·Î Áõ°¡ÇÑ´Ù. |
||
| FH | facial hemihyperplasia; familial hypercholesterolemia; family history; fasting hyperbilirubinemia; f... |
|---|
| posthepatitic cirrhosis | <pathology> This is a form of continuing liver inflammation that results in liver cell death. Causes include viral infection (hepatitis D, hepatitis B, hepatitis C), autoimmune disease, drug ingestion or metabolic causes. Chronic active hepatitis will lead to hepatic failure and death in a small percentage of these patients. (27 Sep 1997) |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|